Schedule 1 – TranscendingSquare

February 23, 2018March 20, 2018

Phospholipid and fertility for men and women

Fertility for both men and women is also effected by having adequate but not too much cannabinoids/phospholipid. Most of the cannabinoid group of molecules do not cause euphoria as does THC, the cannabinoid that medical marijuana is known for containing. The cannabinoid that is most common within the body is more similar to the non-euphoria causing cannabinoid known by the initials CBD.

Political reasons may be the reason that medical research is being prevented by the Schedule 1 status of the marijuana /cannabis plant. Many medical advocacy groups have recommended that the plant be taken off the Scheduled list or have it changed to a lower rating that indicates medical benefit.

So a change in political environment seems necessary before the goal to help save the human race from extinction can be addressed directly with research into improving both the diet and nutrient guidelines for all age groups and address increasing infertility rates. Currently medical professionals can’t really study or recommend cannabinoids for healthcare purposes due to the Federal designation of Schedule 1 controlled substance.

Additional note: The question of legalizing marijuana is seperate from changing the Schedule from I to III. Simply changing the rating would free academic and medical research teams or businesses to work with non-euphoria producing cannabinoids or the effect of dietary sources of phospholipids on the endogenous cannabinoid systems of the body and their effect on promoting health in certain types of chronic illness or substance abuse or binge eating disorders. Ironically a synthetic version of the euphoria producing cannabinoid known as THC is already considered a Schedule III drug (accessdata.fda.gov/Marinol/dronabinol.pdf) – with medical benefits – while the plant that contains a range of cannabinoids and terpenes that all have medical benefits is rated Schedule I – with no medical benefits.

It is past time for politics to get out of the way of health care research.

Disclosure: This information is being provided for the purpose of education within the guidelines of Fair Use. While I am a Registered Dietitian, the information is not intended to be used for the purpose of individualized healthcare guidance. Please seek an individual healthcare professional for the purpose of individualized healthcare guidance.

February 23, 2018March 20, 2018

Phospholipids and infant formula

In the last post I stated my long term goal regarding phospholipids and infant or adult complete diet formulas in simplified terms. The primary complicating factor is the limits that are placed on cannabinoids by the U.S. rating of cannabis/marijuana as a plant with no medical value. As a Schedule 1 controlled substance research is only allowed to be performed regarding toxic or addictive aspects of the plant or substance. Many groups including physician groups have stated that the underlying premise that there is no medical value for cannabis/marijuana is wrong. Phospholipids form one part of the more complex group of molecules called cannabinoids and cannabinoids are found in every cell of the body and in most species of animals and many plants and even a few types of insects. The group of chemicals form a flexible part of cell membranes and also act as messenger chemicals that are important in immunity, appetite control and mood to name a few roles. For infants the nutrients are found in a well nourished woman’s breast milk and it helps promote a good appetite and weight gain for the baby. A chronically ill, elderly, or genetically not average person might also need a dietary source of phospholipids or cannabinoids.

So having a goal of establishing an additional ingredient for infant or adult formula is simplifying the need to have the same group of molecules stated to be of medical value within the controlled substance regulations of the U.S. and other countries. Mexico has changed regulations to state medical value so advances in infant and adult formulas with research to show safety and effectiveness might start there unless or until the U.S. companies work with the simpler phospholipids or the Schedule 1 regulation is changed for cannabis/marijuana at the Federal level.

Disclosure: This information is being provided for educational purposes within the guidelines of Fair Use. While I am a Registered Dietitian this information is not intended to provide individual health care guidance. Please seek an individual health care provider for individualized health care guidance.

November 24, 2017December 3, 2017

Medical marijuana is not the same as an addiction

The need for medical marijuana may be a daily need like any other medication and physical or mental withdrawal symptoms may occur when it is not available just like many other medication.

There can be genetic reasons that someone may need an external source of phospholipids or cannabinoids from food sources throughout their lives for best health or the need may arise during an illness or later in life due to changes associated with aging. The cannabinoid system is involved with many other functions of the body so symptoms can be diverse when there is a lack and cravings for something may occur which may be interpreted incorrectly and other substances may be overused in addictive ways. Overeating food, use of alcohol, nicotine and heroin/opiates products may all be problems that occur with an underlying dysfunction in the person’s ability to make cannabinoids internally the way people of normal physiology are capable. I discuss this topic in more detail and include some legal food sources that are naturally better sources of cannabinoids or phospholipids in an section I wrote for my newer website https://effectivecare.info/addiction-or-starvation%3F

which is also copied onto this site with a few additional details about the salad recipe: Is it Addiction or Starvation?

While I am past the age of having babies, and entered grand parent age the need to reschedule marijuana for the purpose of research may be important for the fertility of younger women and men. The cannabinoid system is essential for both female and male fertility, in a U-shape need – too little or too much can be problems. Overuse of medical or recreational marijuana could interfere with fertility but an underlying deficiency could also be a cause of infertility in either gender.

Infertility problems can be caused by a problem with cannabinoid receptors or an excess or inadequate supply of cannabinoids. Research in the cannabinoid system and its effects on physiology beyond toxicity and addiction are limited due to the federal listing of the cannabis/marijuana plant as a Schedule 1 substance, something considered to have no medical value. However the listing is in error and a number of medical officials and organizations have recommended changing the federal listing. An overview of the research that is available on the cannabinoid system’s role in female and male fertility and reproduction is available here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034092/

The system is involved in the fertilized egg successfully implanting in the woman’s uterus and the cannabinoid system is involved in the male reproductive system in a few ways including the motility of the sperm – are they able to effectively get to where they need to go? A variety of cannabinoids exist and some also have effects on hormonal controls that occur within the brain that effect male reproductive health. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651943/

The balance of cannabinoids is critical and too much use of an external source such as medical marijuana is linked to male infertility, however again a U shape need exists. Some is necessary, too much or too little is a problem.